SCHEMBL7378329

SCHEMBL7378329

NC(=O)CCCCCc1ccccn1

nearest known ligand 0.64

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 2/20 0.64
SMN1; SMN2 Q16637 3/20 0.59
CYP1A2 P05177 2/20 0.59
CYP2C19 P33261 1/20 0.59
NAAA Q02083 1/20 0.50
HDAC1 Q13547 1/20 0.48
PARP10 Q53GL7 1/20 0.45
TDP1 Q9NUW8 2/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
RAB9A P51151 2/20 0.44
NPC1 O15118 1/20 0.44
LMNA P02545 1/20 0.44
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18248625 1.00 HRH1 (0.64) HRH1SMN1; SMN2CYP1A2CYP2C19NAAA
SCHEMBL7376400 0.98 SMN1; SMN2 (0.61) HRH1SMN1; SMN2CYP1A2CYP2C19NAAA
SCHEMBL9774 0.93 SMN1; SMN2 (0.68) HRH1SMN1; SMN2CYP1A2CYP2C19PARP10
Hydrochloric Acid SCHEMBL3513717 0.91 SMN1; SMN2 (0.66) HRH1SMN1; SMN2CYP1A2CYP2C19PARP10
SCHEMBL18248489 0.91 HRH1 (0.54) HRH1SMN1; SMN2CYP1A2CYP2C19NAAA
SCHEMBL18248642 0.91 HRH1 (0.54) HRH1SMN1; SMN2CYP1A2CYP2C19NAAA
SCHEMBL18248609 0.89 HRH1 (0.51) HRH1SMN1; SMN2CYP1A2CYP2C19NAAA
SCHEMBL9658041 0.88 SMN1; SMN2 (0.61) HRH1SMN1; SMN2CYP1A2CYP2C19NAAA
SCHEMBL626826 0.87 HRH1 (0.57) HRH1SMN1; SMN2CYP1A2CYP2C19PARP10
SCHEMBL2960008 0.86 SMN1; SMN2 (0.64) HRH1SMN1; SMN2CYP1A2CYP2C19NAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5030642-A Antitumor agents G. D. SEARLE & CO. (US) 1991-07-09 US disclosed
EP-0310015-A2 Renin-inhibiting dipeptides, process for their preparation, medicines containing them and their use HOECHST AKTIENGESELLSCHAFT (DE) 1989-04-05 EP disclosed